Latest filing published 19 Mar 2023 for Knight Therapeutics Inc., €1,397.
No signal scores available.
Ricardo Adolfo Montejo discloses dealings in Knight Therapeutics Inc. to SEDI. Over a trading history stretching from 1 September 2021 to 15 March 2023, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 19 March 2023: a share grant of €1,397, in Knight Therapeutics Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations